GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of A1c: the version I wish someone had shown me in week 1 — 21 comments in the full submission. View in context.
397
c/t2dglp1·submitted 9 months ago by u/source_or_silence

A1c: the version I wish someone had shown me in week 1

Questionbranch of 6 comments

A1c: the version I wish someone had shown me in week 1. Numbers below. Ask me the boring questions, they are the useful ones. A1c reflects average glycaemia over roughly the preceding three months, weighted towards the most recent weeks. It cannot show variability and it lags any change you make. Postprandial…

Read the full submission and all 21 comments →

This branch

6 comments, started 9 months ago
u/nhs_waitlist_nUK27 points·9 months ago

The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.

replysharereportpermalink
u/source_or_silenceOP10 points·9 months ago

Time in range told me far more than the average did. Two quarters with the same A1c looked completely different on the sensor.

replysharereportpermalink
u/hana_lehtinen3 points·9 months ago

dose for glycaemic control is not the same conversation as dose for weight

replysharereportpermalink
u/fasting_insulin_fMOD14 points·9 months ago

Left up. It distinguishes the sensor data from the lab result, which most posts here do not.

replysharereportpermalink
u/source_or_silenceOP8 points·9 months ago·edited

That is a sensor value, not a plasma value, and the two are not interchangeable at that level of precision.

replysharereportpermalink
u/runa_grimaldi2 points·9 months ago

Yes — time in range tells you about variability, which the average deliberately hides.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/t2dglp1
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/a1c_arcu/fasting_insulin_fu/gentle_correction
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →